Epidemiology of Decompensated Heart Failure in the City of Niterói - EPICA - Niterói Project;Epidemiologia da Insuficiência Cardíaca Descompensada em Niterói - Projeto EPICA - Niterói

Arquivos Brasileiros de Cardiologia

Volumn 82, Issue 2, 2004, Pages 121-128

  Tavares, Leandro Reis ^a,b   Victer, Heraldo ^a   Linhares, José Maurício ^a   Monteiro De Barros, Clovis ^a   Oliveira, Marcus Vinicius ^a   Pacheco, Luis Carlos ^a   Viana, Cenésio Henrique ^a   Bernardez Pereira, Sabrina ^a   Pinto Da Silva, Gisele ^a   Tinoco Mesquita, Evandro ^a  

^a HOSPITAL UNIVERSITÁRIO ANTÔNIO PEDRO   (Brazil)

^b NONE   (Brazil)

Author keywords

Epidemiology; Heart failure; Niter i

Indexed keywords

ADULT; AGED; ARTICLE; BRAZIL; CHI SQUARE TEST; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; FEMALE; FISHER EXACT TEST; HEART FAILURE; HUMAN; INCOME; ISCHEMIC HEART DISEASE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIVATE HOSPITAL; PROSPECTIVE STUDY; PUBLIC HOSPITAL; READING; RISK FACTOR; SMOKING; SOCIOECONOMICS;

EID: 12144286853     PISSN: 0066782X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Anderson B, Waagstein F. Spectrum and outcome of congestive heart failure in a hospitalized population. Am Heart J 1993; 126: 632-40.
2. Ho KKL, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham study. J Am Coll Cardiol 1993; 22: Suppl A: 6A-13A.
3. 2001 Heart and Stroke Statistical Update da American Heart Association
4. DATASUS 2000 (www.datasus.gov.br).
5. McKee PA, Castelli WP, McNamara PM, Kannerl WB. The natural history of congestive heart failure: the Framingham study. N Engl J Med 1971; 285: 1141-6.
6. Villacorta H, Rocha N, Cardoso R. Evolução intra-hospitalar e seguimento pósalta de pacientes com insuficiência cardíaca congestiva na unidade de emergência. Arq Bras Cardiol 1998; 70: 167-71.
7. Philbin FE, Dec GW, Jenkins PL, DiSalvo TG. Socioeconomic status as an independent risk factor for hospital readmission for heart failure. Am J Cardiol 2001; 87: 1367-71.
8. Instituto Brasileiro de Geografia e Estatística (www.ibge.gov.br)
9. Barreto ACP, Nobre MRC, Wajngarten M, Canesin MF, Ballas D, Serro-Azul JB. Insuficiência cardíaca em um grande hospital terciário de Sao Paulo. Arq. Bras. Cardiol. 1998; 71: 15-20.
10. Croft JB, Giles WH, Pollard RA, Keenan NL, Carper ML, Anda RF. Heart failure survival among older adults in the United States: a poor prognosis for an emerging epidemic in the Medicare population. Arch Intern Med 1999; 159: 505-10.
11. Bart BA, Shaw LK, McCants CB, Fortin DF, Lee KL, Calif RM, O'Connor CM. Clinical determinants of mortality in patients with angiographically diagnosed ischaemic or non ischaemic cardiomiopathy. Cardiol 1997; 30: 1002-8.
12. Cohn JN, Tognoni G, Glazer RD, Spormann D, Hester A. Rationale and design of Valsartan Heart Failure Trial: large multinational trial to assess the effects of valsartan on morbidity and mortality in chronic congestive heart failure. J Card Fail 1999; 5: 155-60.
13. Parameshwar J, Keegan J, Sparrow J, Sutton G, Poole-Wilson PA. Predictors of prognosis in severe chronic heart failure. Am Heart J 1992; 123: 421-6.
14. Maghert M, Persson H, Edner M, Kahan T. Epidemiology of heart failure in Sweeden - a national survey. Eur Heart J 2001; 3: 97-103.